The University of Tokyo Edge Capital

Eureka Robotics is a technology company that specializes in developing robotic systems and software aimed at automating tasks that require high accuracy and agility. Drawing on research from prestigious institutions such as NTU Singapore and MIT, the company provides solutions that enhance productivity, reduce costs, and improve safety in various manufacturing processes. Its offerings are applicable across a range of industries, including healthcare, telecommunications, automotive, photonics, electronics, and aerospace. With offices located in Singapore, France, and Vietnam, and distribution partners in China, Japan, and the United States, Eureka Robotics is committed to enabling clients to efficiently manage complex tasks such as precision handling, assembly, inspection, and drilling, allowing human workers to focus more on creative activities rather than routine decisions.

Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It focuses on digital transformation within the commercial real estate market by offering an online platform that includes services such as market research and algorithms for rent estimation. Estie's software solutions aim to enhance the efficiency of information flow and transactions in the industry, enabling clients to make informed, data-driven decisions. Through its innovative approach, Estie seeks to unlock the value of commercial real estate by providing tools that improve decision-making processes for its users.

United Immunity, Co., Ltd., established on November 27, 2017, and headquartered in Tsu, Japan, specializes in the research, development, manufacture, and sales of pharmaceuticals, with a primary focus on cancer immunotherapy. The company is known for its innovative use of nanoparticles and lipid nanoparticles to target myeloid cells, facilitating the delivery of therapeutic agents directly to macrophages and dendritic cells. This technology supports the development of treatments for a range of conditions, including cancer, autoimmune diseases, fibrosis, and infectious diseases. United Immunity aims to advance therapeutic options and improve patient outcomes through its specialized research and development efforts.

Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.

HashPort, founded in 2018, assists emerging web3 businesses by providing development support and financing through Initial Exchange Offerings (IEOs). The company specializes in creating crypto-asset products, including digital wallets and non-fungible token (NFT) platforms. In 2020, it launched HashPalette, a subsidiary that achieved a milestone by conducting Japan's first approved IEO and developing a dedicated blockchain for NFTs, along with operating one of the country’s largest NFT marketplaces. In April 2023, HashPort secured over 1.2 billion yen in a Series C funding round led by six underwriters. The firm also offers consulting services aimed at helping crypto-asset exchange companies explore and implement blockchain technologies, further facilitating the digitalization of assets.

OriCiro Genomics, Inc. is a biotechnology company based in Minato-ku, Japan, founded in 2018. It specializes in the research and development of innovative technologies for the cell-free synthesis and amplification of large DNA molecules. The company's core offerings include DNA assembly and circular DNA amplification technologies, which enable the construction of large circular DNA molecules without the need for traditional biological cloning methods. OriCiro Genomics aims to facilitate advancements in synthetic biology, providing its products to various sectors, including pharmaceuticals, diagnostics, food, and agriculture. By harnessing these technologies, the company seeks to contribute to a more efficient bioeconomy and promote new possibilities in gene therapy and related fields.

Eureka Robotics is a technology company that specializes in developing robotic systems and software aimed at automating tasks that require high accuracy and agility. Drawing on research from prestigious institutions such as NTU Singapore and MIT, the company provides solutions that enhance productivity, reduce costs, and improve safety in various manufacturing processes. Its offerings are applicable across a range of industries, including healthcare, telecommunications, automotive, photonics, electronics, and aerospace. With offices located in Singapore, France, and Vietnam, and distribution partners in China, Japan, and the United States, Eureka Robotics is committed to enabling clients to efficiently manage complex tasks such as precision handling, assembly, inspection, and drilling, allowing human workers to focus more on creative activities rather than routine decisions.

Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.

Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.

OriCiro Genomics, Inc. is a biotechnology company based in Minato-ku, Japan, founded in 2018. It specializes in the research and development of innovative technologies for the cell-free synthesis and amplification of large DNA molecules. The company's core offerings include DNA assembly and circular DNA amplification technologies, which enable the construction of large circular DNA molecules without the need for traditional biological cloning methods. OriCiro Genomics aims to facilitate advancements in synthetic biology, providing its products to various sectors, including pharmaceuticals, diagnostics, food, and agriculture. By harnessing these technologies, the company seeks to contribute to a more efficient bioeconomy and promote new possibilities in gene therapy and related fields.

Startbahn, Inc. is a Tokyo-based company founded in 2014 that focuses on enhancing the art experience in the digital era. It operates a platform designed for artists and those involved in the art community, providing essential technological support. Startbahn is developing Startbahn Cert., a service that utilizes blockchain technology to issue certificates for artworks, which helps ensure authenticity and provenance. The company also promotes Startrail, a blockchain infrastructure that underpins Startbahn Cert. Additionally, Startbahn offers a certificate management system that allows users to access registration information via smartphone and provides a marketplace for buyers to discover artworks. Through these services, Startbahn aims to facilitate the management of art collections and improve the overall accessibility and integrity of the art market.

DataFluct Inc., founded in 2019 and headquartered in Chiyoda City, Japan, offers a free satellite image search service that allows users to access satellite imagery. As a subsidiary of Factorium Inc., DataFluct specializes in data management and machine learning services aimed at addressing corporate and social challenges through data science. The company focuses on developing sustainable algorithms that optimize solutions while considering environmental, social, customer, and economic values. Additionally, DataFluct operates as a data science startup studio, utilizing full-stack technology for data collection, storage, analysis, and application. This enables businesses to predict future trends and derive value from previously underutilized data, ultimately fostering innovation and growth.

HashPort, founded in 2018, assists emerging web3 businesses by providing development support and financing through Initial Exchange Offerings (IEOs). The company specializes in creating crypto-asset products, including digital wallets and non-fungible token (NFT) platforms. In 2020, it launched HashPalette, a subsidiary that achieved a milestone by conducting Japan's first approved IEO and developing a dedicated blockchain for NFTs, along with operating one of the country’s largest NFT marketplaces. In April 2023, HashPort secured over 1.2 billion yen in a Series C funding round led by six underwriters. The firm also offers consulting services aimed at helping crypto-asset exchange companies explore and implement blockchain technologies, further facilitating the digitalization of assets.

Metcela Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for cardiac diseases. Founded in 2016 and based in Kawasaki, Japan, Metcela specializes in fibroblast-based treatments, particularly its lead asset, MTC001. This therapy utilizes VCAM-1-positive Cardiac Fibroblasts, which are derived from the patient's own heart cells. Rather than replacing damaged cells, the therapy enhances the body's natural healing processes to repair heart tissue and restore a favorable microenvironment. Through its research and development efforts, Metcela aims to offer patients an effective and affordable alternative for treating heart failure.

Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.

Epigeneron, Inc. is a biotechnology company based in Chuo, Japan, focused on the research, development, manufacturing, and marketing of pharmaceutical drugs. Founded in 2015, the company specializes in creating treatments for a range of serious conditions, including cancer, dementia, metabolic disorders, and infectious diseases. Epigeneron is recognized for its expertise in drug discovery and offers services related to the development of epigenetic and anti-microbial drugs. The company employs advanced techniques such as chromatin immunoprecipitation to identify specific genomic interactions, which aids in the development of gene therapies aimed at treating severe immune diseases and other disorders affecting the central nervous system. Additionally, Epigeneron is involved in the manufacture and sale of research reagents, diagnostic agents, and related research equipment, as well as the transfer of intellectual property associated with its innovations.

BionicM is a Tokyo-based company focused on researching, developing, and commercializing advanced mobility devices that integrate robotics with the human body. Established as a joint-stock company in 2018, BionicM specializes in high-performance robotic prosthetics, including ankle-foot and knee joints, designed to enhance mobility for individuals with disabilities. The company has been engaged in innovative technology research since 2015 at the University of Tokyo's Information Systems Engineering Laboratory, working under the guidance of Professor Inaba. BionicM's products aim to enable users, including both handicapped and non-handicapped individuals, to perform essential daily activities such as standing, walking, and climbing stairs.

Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It focuses on digital transformation within the commercial real estate market by offering an online platform that includes services such as market research and algorithms for rent estimation. Estie's software solutions aim to enhance the efficiency of information flow and transactions in the industry, enabling clients to make informed, data-driven decisions. Through its innovative approach, Estie seeks to unlock the value of commercial real estate by providing tools that improve decision-making processes for its users.

TXP Medical, Inc. specializes in the development and sale of patient information recording and management systems. Founded in 2017 and based in Bunkyo, Japan, the company offers a range of products including the NEXTStage ER platform, which supports medical record input and clinical research, as well as mobile applications that facilitate patient information entry through voice commands and image recognition. TXP Medical aims to enhance decision-making in the medical field by creating a comprehensive data platform for emergency outpatients, enabling hospitals to digitize emergency medical care. The company's offerings also include a self-assessment system that allows patients to input their own data, contributing to improved healthcare delivery and quality of life.

Goryo Chemical, Inc. is a company based in Sapporo, Japan, with an additional office in Tokyo, that specializes in the development and sales of fluorescent probes and functional dyes for chemical biology and bio applications. Founded in 2010, the company offers a range of products and services, including AcidiFluor, CalFluor, GlycoFluor, ProteoFluor, MetalloFluor, ROSFluor, and IndoCyanine green dye series, as well as bioluminescent probes and custom synthesis services. These probes are designed for cellular analysis, assay, and imaging, allowing for selective staining of acidic organelles like lysosomes and late endosomes, which can aid in medical diagnostics and treatment. Goryo Chemical serves a diverse customer base through a network of distributors both in Japan and internationally.

Algal Bio Co., Ltd., established in 2018 and based in Kashiwa, Japan, specializes in the research, development, production, and sale of algae and its components. Drawing on two decades of research from the University of Tokyo, the company focuses on producing rare fatty acids and carotenoids while also engaging in food processing, importing, exporting, and distributing algae and its ingredients. Algal Bio operates a laboratory dedicated to exploring the functionality of microalgae as food ingredients, employing a unique algae bio-foundry platform that integrates various screening and cultivation technologies. The company aims to address significant global challenges, including rising health consciousness, food shortages, and climate change, by applying algae across diverse industries and applications.

Retrieva, Inc. is a technology company based in Tokyo, Japan, specializing in the development of artificial intelligence-based software solutions for call centers. Founded in 2016, the company harnesses natural language processing and machine learning to create innovative products that enhance communication and operational efficiency. Its offerings include Talk Coordinator, an operator software solution; Voice Visualizer, an administrator software solution; and VoC Analyzer, which provides analytical insights. Retrieva's technology is designed to address enterprise customer challenges by delivering user-friendly services that improve inquiry analysis and response support in call center environments.

Mujin Inc. specializes in providing solutions for industrial robotics and factory automation, with a focus on enhancing productivity in manufacturing and logistics. Founded in 2011 and based in Tokyo, the company offers a range of products including the Mujin Controller Sim for programming industrial robots, Mujin Scanner for 3D modeling, Pick Worker for bin-picking with real-time motion planning, and Laser Worker for laser cutting applications. Mujin's intelligent robot controllers address common limitations faced by traditional robots, enabling better adaptability in dynamic environments. The company also provides comprehensive services such as robot system design, controller design, and motion planning, which are crucial for automating both heavy and repetitive tasks. With its advanced motion planning technology, Mujin aims to simplify factory automation and facilitate the integration of robots into complex real-time systems, ultimately streamlining operations that were previously reliant on human labor.

OriCiro Genomics, Inc. is a biotechnology company based in Minato-ku, Japan, founded in 2018. It specializes in the research and development of innovative technologies for the cell-free synthesis and amplification of large DNA molecules. The company's core offerings include DNA assembly and circular DNA amplification technologies, which enable the construction of large circular DNA molecules without the need for traditional biological cloning methods. OriCiro Genomics aims to facilitate advancements in synthetic biology, providing its products to various sectors, including pharmaceuticals, diagnostics, food, and agriculture. By harnessing these technologies, the company seeks to contribute to a more efficient bioeconomy and promote new possibilities in gene therapy and related fields.

Startbahn, Inc. is a Tokyo-based company founded in 2014 that focuses on enhancing the art experience in the digital era. It operates a platform designed for artists and those involved in the art community, providing essential technological support. Startbahn is developing Startbahn Cert., a service that utilizes blockchain technology to issue certificates for artworks, which helps ensure authenticity and provenance. The company also promotes Startrail, a blockchain infrastructure that underpins Startbahn Cert. Additionally, Startbahn offers a certificate management system that allows users to access registration information via smartphone and provides a marketplace for buyers to discover artworks. Through these services, Startbahn aims to facilitate the management of art collections and improve the overall accessibility and integrity of the art market.

Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It focuses on digital transformation within the commercial real estate market by offering an online platform that includes services such as market research and algorithms for rent estimation. Estie's software solutions aim to enhance the efficiency of information flow and transactions in the industry, enabling clients to make informed, data-driven decisions. Through its innovative approach, Estie seeks to unlock the value of commercial real estate by providing tools that improve decision-making processes for its users.

BionicM is a Tokyo-based company focused on researching, developing, and commercializing advanced mobility devices that integrate robotics with the human body. Established as a joint-stock company in 2018, BionicM specializes in high-performance robotic prosthetics, including ankle-foot and knee joints, designed to enhance mobility for individuals with disabilities. The company has been engaged in innovative technology research since 2015 at the University of Tokyo's Information Systems Engineering Laboratory, working under the guidance of Professor Inaba. BionicM's products aim to enable users, including both handicapped and non-handicapped individuals, to perform essential daily activities such as standing, walking, and climbing stairs.

PharmaBio Corporation is a health care company based in Nagoya, Japan, specializing in the contract development and manufacturing of cellular and tissue-based products. Established in 1978, the company focuses on developing cell-based investigational new drugs and provides a range of services, including microbial safety testing, specimen storage, and genetic testing for pathogenic viruses. PharmaBio operates a Good Manufacturing Practice (GMP)-compliant facility for the storage of cell-based drugs and test specimens. Additionally, the company offers strategic development consultation and research services to support the regulatory development of cell and tissue-based medicine. By emphasizing safety and quality, PharmaBio aims to enhance the production of improved-quality medical products derived from living cells and tissues, contributing to advancements in regenerative medicine.

Socium Inc., based in Japan, is an AI-powered company specializing in drug discovery and development, focusing on first-in-class small molecules. The organization has a diverse development portfolio addressing over 23 diseases, including oncology and rare diseases. By employing an in-silico system bolstered by advanced algorithms, Socium streamlines the traditional drug discovery process, significantly reducing the time required to identify drug discovery targets to just a few months. The company utilizes a systems biology approach, leveraging augmented intelligence and machine learning to analyze comprehensive OMICS data rather than merely hypothesizing disease mechanisms. This methodology also allows for drug repositioning, enabling the healthcare industry to uncover new therapeutic uses for existing pharmaceuticals.

Neural Pocket Inc. is a technology company based in Tokyo, Japan, that specializes in developing proprietary AI technologies focused on image and video analysis. Founded in 2018, the company offers a range of services aimed at creating smart cities, including solutions for mobility, facility and infrastructure management, and security through people and object movement tracking. Additionally, Neural Pocket provides digital signage services tailored for advertisers, developers, and commercial facilities. The firm also offers AI-driven fashion trend analysis, utilizing data from social networking and shopping sites to provide insights into fashion trends. Formerly known as Fashion Pocket Inc., the company rebranded in March 2019 to reflect its broader focus on AI applications beyond the fashion industry.

AI Inside Inc. is a Tokyo-based company specializing in artificial intelligence and software development, particularly focusing on optical character recognition (OCR) services. Founded in 2015, AI Inside is dedicated to facilitating the digital transformation of society by converting various forms of information into digital data. The company offers an AI-powered platform known as the DX Suite, which aims to enhance productivity across different sectors. Through its innovative algorithms, AI Inside contributes to the advancement of a digital society by streamlining data processing and improving operational efficiency for its clients.

Startbahn, Inc. is a Tokyo-based company founded in 2014 that focuses on enhancing the art experience in the digital era. It operates a platform designed for artists and those involved in the art community, providing essential technological support. Startbahn is developing Startbahn Cert., a service that utilizes blockchain technology to issue certificates for artworks, which helps ensure authenticity and provenance. The company also promotes Startrail, a blockchain infrastructure that underpins Startbahn Cert. Additionally, Startbahn offers a certificate management system that allows users to access registration information via smartphone and provides a marketplace for buyers to discover artworks. Through these services, Startbahn aims to facilitate the management of art collections and improve the overall accessibility and integrity of the art market.

Fressets, Inc., established in 2017 and based in Tokyo, Japan, specializes in developing cryptocurrency wallet systems for virtual currency exchanges. The company's core business is an enterprise wallet management (EWM) system, primarily serving cryptocurrency exchanges and custodians. This system employs multisignature addresses and secure hardware for key storage, ensuring robust security against hacker threats. It combines the advantages of secure cold wallets and convenient hot wallets, providing clients with a balance of security and scalability for smooth cryptocurrency transactions.

Aidemy Inc. is a Tokyo-based company that offers online artificial intelligence programming services aimed at individuals and enterprises. Founded in 2014, it provides a comprehensive learning platform where users can acquire AI technology skills through practical applications. Aidemy's services include an all-in-one teaching environment and digital transformation support, facilitating the development of digital talent in organizations. Its solutions are particularly beneficial for corporations in the manufacturing sector, as well as smaller companies and academic institutions. Aidemy's offerings range from online learning resources to consulting services that assist businesses in implementing AI and digital transformation initiatives, ensuring effective human resource development and operational support.

Algal Bio Co., Ltd., established in 2018 and based in Kashiwa, Japan, specializes in the research, development, production, and sale of algae and its components. Drawing on two decades of research from the University of Tokyo, the company focuses on producing rare fatty acids and carotenoids while also engaging in food processing, importing, exporting, and distributing algae and its ingredients. Algal Bio operates a laboratory dedicated to exploring the functionality of microalgae as food ingredients, employing a unique algae bio-foundry platform that integrates various screening and cultivation technologies. The company aims to address significant global challenges, including rising health consciousness, food shortages, and climate change, by applying algae across diverse industries and applications.

Socium Inc., based in Japan, is an AI-powered company specializing in drug discovery and development, focusing on first-in-class small molecules. The organization has a diverse development portfolio addressing over 23 diseases, including oncology and rare diseases. By employing an in-silico system bolstered by advanced algorithms, Socium streamlines the traditional drug discovery process, significantly reducing the time required to identify drug discovery targets to just a few months. The company utilizes a systems biology approach, leveraging augmented intelligence and machine learning to analyze comprehensive OMICS data rather than merely hypothesizing disease mechanisms. This methodology also allows for drug repositioning, enabling the healthcare industry to uncover new therapeutic uses for existing pharmaceuticals.

Epigeneron, Inc. is a biotechnology company based in Chuo, Japan, focused on the research, development, manufacturing, and marketing of pharmaceutical drugs. Founded in 2015, the company specializes in creating treatments for a range of serious conditions, including cancer, dementia, metabolic disorders, and infectious diseases. Epigeneron is recognized for its expertise in drug discovery and offers services related to the development of epigenetic and anti-microbial drugs. The company employs advanced techniques such as chromatin immunoprecipitation to identify specific genomic interactions, which aids in the development of gene therapies aimed at treating severe immune diseases and other disorders affecting the central nervous system. Additionally, Epigeneron is involved in the manufacture and sale of research reagents, diagnostic agents, and related research equipment, as well as the transfer of intellectual property associated with its innovations.

Neural Pocket Inc. is a technology company based in Tokyo, Japan, that specializes in developing proprietary AI technologies focused on image and video analysis. Founded in 2018, the company offers a range of services aimed at creating smart cities, including solutions for mobility, facility and infrastructure management, and security through people and object movement tracking. Additionally, Neural Pocket provides digital signage services tailored for advertisers, developers, and commercial facilities. The firm also offers AI-driven fashion trend analysis, utilizing data from social networking and shopping sites to provide insights into fashion trends. Formerly known as Fashion Pocket Inc., the company rebranded in March 2019 to reflect its broader focus on AI applications beyond the fashion industry.

Autonomous Control Systems Laboratory Ltd. is an industrial drone manufacturer and solution provider based in Tokyo, Japan, founded in 1998 from the laboratory of Professor Kenzo Nonami at Chiba University. The company specializes in the development, production, and servicing of fully automated drones designed for a wide range of applications, including delivery, inspection, disaster relief, logistics, aerial photography, and surveying. With a focus on research and development, ACSL utilizes proprietary technologies developed in Japan to contribute to the advancement of industrial drone solutions. The company aims to be at the forefront of the new industrial revolution in the global skies, providing innovative solutions for various industrial needs.

PharmaBio Corporation is a health care company based in Nagoya, Japan, specializing in the contract development and manufacturing of cellular and tissue-based products. Established in 1978, the company focuses on developing cell-based investigational new drugs and provides a range of services, including microbial safety testing, specimen storage, and genetic testing for pathogenic viruses. PharmaBio operates a Good Manufacturing Practice (GMP)-compliant facility for the storage of cell-based drugs and test specimens. Additionally, the company offers strategic development consultation and research services to support the regulatory development of cell and tissue-based medicine. By emphasizing safety and quality, PharmaBio aims to enhance the production of improved-quality medical products derived from living cells and tissues, contributing to advancements in regenerative medicine.

Provigate is a Japanese company specializing in bio-transistor sensor technologies that focus on health management. The company has developed diagnostic instruments capable of measuring blood sugar levels in patients, utilizing advanced perception-broadening sensors. These sensors enable users to monitor dynamic changes in their glucose levels, facilitating better lifestyle management for individuals, particularly those with diabetes. By providing tools that allow for regular monitoring, Provigate aims to assist users in adapting their habits to improve their overall health and well-being.

Autonomous Control Systems Laboratory Ltd. is an industrial drone manufacturer and solution provider based in Tokyo, Japan, founded in 1998 from the laboratory of Professor Kenzo Nonami at Chiba University. The company specializes in the development, production, and servicing of fully automated drones designed for a wide range of applications, including delivery, inspection, disaster relief, logistics, aerial photography, and surveying. With a focus on research and development, ACSL utilizes proprietary technologies developed in Japan to contribute to the advancement of industrial drone solutions. The company aims to be at the forefront of the new industrial revolution in the global skies, providing innovative solutions for various industrial needs.

Aidemy Inc. is a Tokyo-based company that offers online artificial intelligence programming services aimed at individuals and enterprises. Founded in 2014, it provides a comprehensive learning platform where users can acquire AI technology skills through practical applications. Aidemy's services include an all-in-one teaching environment and digital transformation support, facilitating the development of digital talent in organizations. Its solutions are particularly beneficial for corporations in the manufacturing sector, as well as smaller companies and academic institutions. Aidemy's offerings range from online learning resources to consulting services that assist businesses in implementing AI and digital transformation initiatives, ensuring effective human resource development and operational support.

FLOSFIA INC. is a Tokyo-based company that specializes in developing corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, as a spin-off from research at Kyoto University, the company focuses on film formation through mist chemical vapor deposition. FLOSFIA's products are characterized by high breakdown voltage and efficiency, aimed at creating low-loss power devices that leverage the advantageous properties of gallium oxide (Ga2O3).

NS Materials Corp. is a manufacturer and distributor of semiconductor-related equipment and systems based in Chikushino-shi, Japan. The company focuses on developing micro-space chemical technologies, particularly specializing in nano-phosphor for LED lighting and innovative chemical synthesis techniques. By advancing these technologies, NS Materials aims to establish a new field within nanotechnology and biotechnology. Their offerings are designed to provide clients with tools and products that contribute to a low-carbon society, significantly impacting daily life and promoting sustainability.

Retrieva, Inc. is a technology company based in Tokyo, Japan, specializing in the development of artificial intelligence-based software solutions for call centers. Founded in 2016, the company harnesses natural language processing and machine learning to create innovative products that enhance communication and operational efficiency. Its offerings include Talk Coordinator, an operator software solution; Voice Visualizer, an administrator software solution; and VoC Analyzer, which provides analytical insights. Retrieva's technology is designed to address enterprise customer challenges by delivering user-friendly services that improve inquiry analysis and response support in call center environments.

Routrek Networks, Inc. is a company based in Kawasaki, Japan, founded in 2005, that specializes in hardware and software solutions for network systems. The company focuses on advancing the Internet of Things (IoT) to promote sustainable farming practices, addressing food-related challenges through innovative technologies. Routrek Networks offers an automatic irrigation system that integrates sensors and agricultural equipment to optimize irrigation based on soil moisture levels. This system enables remote monitoring and enhances crop yields for small to mid-sized farmers. Additionally, the company provides RouteMagic, a network monitoring system that includes both RouteMagic Server and RouteMagic Console Manager, further supporting efficient agricultural operations.

Goryo Chemical, Inc. is a company based in Sapporo, Japan, with an additional office in Tokyo, that specializes in the development and sales of fluorescent probes and functional dyes for chemical biology and bio applications. Founded in 2010, the company offers a range of products and services, including AcidiFluor, CalFluor, GlycoFluor, ProteoFluor, MetalloFluor, ROSFluor, and IndoCyanine green dye series, as well as bioluminescent probes and custom synthesis services. These probes are designed for cellular analysis, assay, and imaging, allowing for selective staining of acidic organelles like lysosomes and late endosomes, which can aid in medical diagnostics and treatment. Goryo Chemical serves a diverse customer base through a network of distributors both in Japan and internationally.

SEAOS, Inc. is a Tokyo-based company founded in 2000 that specializes in developing software applications for the logistics industry. The company offers a range of services, including logistics strategy consulting, product licensing application software, and the development of robotic solutions tailored for logistics operations. Through its innovative software and consulting services, SEAOS aims to enhance efficiency and effectiveness in the logistics sector.

ReasonWhy Inc. is a Japan-based company founded on July 7, 2011, that specializes in healthcare IT services. The company offers four main services: Whytlink, a social network designed for doctors; Findme, an online second-opinion service that connects patients with doctors from the Whytlink network; WhytPlot, a big-data analysis tool aimed at pharmaceutical manufacturers in Japan; and yourHospital, a search engine that helps users find specialist hospitals. Through these services, ReasonWhy seeks to enhance communication and information sharing within the medical community while improving patient access to healthcare resources.

Autonomous Control Systems Laboratory Ltd. is an industrial drone manufacturer and solution provider based in Tokyo, Japan, founded in 1998 from the laboratory of Professor Kenzo Nonami at Chiba University. The company specializes in the development, production, and servicing of fully automated drones designed for a wide range of applications, including delivery, inspection, disaster relief, logistics, aerial photography, and surveying. With a focus on research and development, ACSL utilizes proprietary technologies developed in Japan to contribute to the advancement of industrial drone solutions. The company aims to be at the forefront of the new industrial revolution in the global skies, providing innovative solutions for various industrial needs.

Liquid, Inc. is a Tokyo-based company founded in 2013 that specializes in the manufacture and development of biometric identity verification and payment devices. The company focuses on fingerprint sensing technology, which enables users to register payment methods, such as point cards and credit cards, using their fingerprint information. This innovative approach allows customers to complete transactions simply by using their fingerprints. Liquid also develops related software that employs advanced authentication algorithms and image analysis technology to enhance security and convenience in payment processes.

MONEY DESIGN Co., Ltd. is a fintech company based in Tokyo, Japan, founded in 2013. The firm specializes in asset management and investment advisory services, providing automated investment management solutions to its clients. By leveraging technology, MONEY DESIGN aims to simplify the investment process and make financial advice more accessible to a broader audience.

FLOSFIA INC. is a Tokyo-based company that specializes in developing corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, as a spin-off from research at Kyoto University, the company focuses on film formation through mist chemical vapor deposition. FLOSFIA's products are characterized by high breakdown voltage and efficiency, aimed at creating low-loss power devices that leverage the advantageous properties of gallium oxide (Ga2O3).

CREWT Medical Systems, Inc., founded in 2013 and based in Tokyo, Japan, specializes in the manufacturing of innovative medical devices. The company is known for developing the world's first head-mounted perimeter, which is compatible with standard automated perimeters, utilizing advanced lens design and software engineering. CREWT aims to create new value by integrating existing technologies to enhance clinical practices. The company's mission focuses on delivering human-centric medical devices that improve quality of vision, reflecting its commitment to innovation in the medical field.

Seven Dreamers Laboratories, Inc. is a Tokyo-based company that specializes in designing and manufacturing innovative medical devices and personal-use technology. Founded in 2011, the company is known for its commitment to developing unique, world-first products. One of its notable creations is the Laundroid, a laundry-folding robot that employs image-recognition algorithms and artificial intelligence to identify various types of clothing, fold them accordingly, and sort them by item or family member. This technology aims to significantly enhance everyday life by automating household chores, thereby allowing users to spend their time on more meaningful activities.

Vegetalia, Inc. is an agricultural technology company based in Tokyo, Japan, established in 2010. The company specializes in developing and marketing measurement monitoring systems and cloud-based application solutions tailored for the agricultural industry. Its flagship products include FieldServer, which integrates field sensors with web and mobile applications for outdoor monitoring, and PaddyWatch, a water management system specifically designed for rice cultivation. Additionally, Vegetalia offers agri-note, a cloud service that supports field management and work analysis. The company employs IoT technology and data analytics to optimize farming practices, enabling agricultural professionals and farmers to efficiently monitor and manage their fields. Vegetalia also operates plant clinics, further enhancing its commitment to sustainable agricultural practices.

Goryo Chemical, Inc. is a company based in Sapporo, Japan, with an additional office in Tokyo, that specializes in the development and sales of fluorescent probes and functional dyes for chemical biology and bio applications. Founded in 2010, the company offers a range of products and services, including AcidiFluor, CalFluor, GlycoFluor, ProteoFluor, MetalloFluor, ROSFluor, and IndoCyanine green dye series, as well as bioluminescent probes and custom synthesis services. These probes are designed for cellular analysis, assay, and imaging, allowing for selective staining of acidic organelles like lysosomes and late endosomes, which can aid in medical diagnostics and treatment. Goryo Chemical serves a diverse customer base through a network of distributors both in Japan and internationally.

Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.

Quantum Biosystems Inc. is a biotechnology company focused on the development of quantum bio sequencing technologies. Founded on January 7, 2013, and based in Yodogawa-ku, Japan, the company specializes in innovative single-molecule DNA and RNA sequencing systems designed for comprehensive genomic analysis. By applying principles of quantum mechanics, Quantum Biosystems aims to enhance the efficiency and accuracy of genetic data collection. Their systems facilitate accelerated DNA and RNA sequencing, enabling researchers to access and interpret genetic information more effectively. This technology promotes advancements in various fields of research, allowing clients to unlock complex genetic codes and further their scientific inquiries.

Molcure, Inc. is a biopharmaceutical company based in Tokyo, Japan, specializing in the development of systems and technologies for pharmaceutical companies focused on antibody drug discovery. Founded in 2013, Molcure offers innovative solutions such as Abtracer, an antibody sequence screening system that identifies functional antibodies, and SmartLabModule, an IoT platform designed for scientific applications. The company combines expertise in next-generation sequencing, bioinformatics, and antibody biology with advanced automated discovery systems to enhance the efficiency of therapeutic antibody development. With a commitment to improving patient outcomes, Molcure aims to be a preferred partner in antibody and peptide drug discovery, actively seeking new collaboration opportunities to further validate and expand its technology.

Mujin Inc. specializes in providing solutions for industrial robotics and factory automation, with a focus on enhancing productivity in manufacturing and logistics. Founded in 2011 and based in Tokyo, the company offers a range of products including the Mujin Controller Sim for programming industrial robots, Mujin Scanner for 3D modeling, Pick Worker for bin-picking with real-time motion planning, and Laser Worker for laser cutting applications. Mujin's intelligent robot controllers address common limitations faced by traditional robots, enabling better adaptability in dynamic environments. The company also provides comprehensive services such as robot system design, controller design, and motion planning, which are crucial for automating both heavy and repetitive tasks. With its advanced motion planning technology, Mujin aims to simplify factory automation and facilitate the integration of robots into complex real-time systems, ultimately streamlining operations that were previously reliant on human labor.

Nabiq Inc. specializes in outsourcing services for wireless broadband environments, focusing on the integration of existing fixed broadband lines with Wi-Fi application technology. The company offers solutions such as radio zone design, installation, and operation of wireless broadband environments tailored for various local settings, including hotels, hospitals, condominiums, and schools. Utilizing a cloud-based platform, Nabiq enables secure connections for smartphones and tablets, creating a terminal-free access environment. Founded in 2013 and headquartered in Chiyoda, Japan, Nabiq operates as a subsidiary of JTOWER Inc.

MONEY DESIGN Co., Ltd. is a fintech company based in Tokyo, Japan, founded in 2013. The firm specializes in asset management and investment advisory services, providing automated investment management solutions to its clients. By leveraging technology, MONEY DESIGN aims to simplify the investment process and make financial advice more accessible to a broader audience.

Quantum Biosystems Inc. is a biotechnology company focused on the development of quantum bio sequencing technologies. Founded on January 7, 2013, and based in Yodogawa-ku, Japan, the company specializes in innovative single-molecule DNA and RNA sequencing systems designed for comprehensive genomic analysis. By applying principles of quantum mechanics, Quantum Biosystems aims to enhance the efficiency and accuracy of genetic data collection. Their systems facilitate accelerated DNA and RNA sequencing, enabling researchers to access and interpret genetic information more effectively. This technology promotes advancements in various fields of research, allowing clients to unlock complex genetic codes and further their scientific inquiries.

GlyTech, Inc. specializes in the production of human-type N-glycans and the development of glycosylation technologies, including glycopeptide and glycoprotein synthesis. Founded in 2012 and based in Kyoto, Japan, the company focuses on enhancing the development of biopharmaceuticals and oligonucleotide therapeutics through innovative glycan production techniques. GlyTech offers a range of services, including custom synthesis, contract research and development, and the licensing of glycosylated peptides and proteins. Additionally, the company supplies standard reagents, supporting researchers in their efforts to advance human health by expanding their capabilities in glycoscience research and biotherapeutic analysis.

Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.

Prometech Software, Inc., founded in 2004 and based in Tokyo, Japan, specializes in the development of virtual reality technologies and innovative computer-aided engineering (CAE) solutions. The company focuses on fluid simulation through the application of the Particle Method, offering advanced fluid analysis tools that aid in product development. Prometech's software enables the creation of interactive virtual environments utilizing state-of-the-art physics simulation and computer graphics technology, making it a key player in the field of interactive reality.

Mujin Inc. specializes in providing solutions for industrial robotics and factory automation, with a focus on enhancing productivity in manufacturing and logistics. Founded in 2011 and based in Tokyo, the company offers a range of products including the Mujin Controller Sim for programming industrial robots, Mujin Scanner for 3D modeling, Pick Worker for bin-picking with real-time motion planning, and Laser Worker for laser cutting applications. Mujin's intelligent robot controllers address common limitations faced by traditional robots, enabling better adaptability in dynamic environments. The company also provides comprehensive services such as robot system design, controller design, and motion planning, which are crucial for automating both heavy and repetitive tasks. With its advanced motion planning technology, Mujin aims to simplify factory automation and facilitate the integration of robots into complex real-time systems, ultimately streamlining operations that were previously reliant on human labor.

Phyzios is a start-up software company based at the University of Tokyo, Japan. Founded in January 2009, the company has developed several successful iPhone and iPod touch applications that have consistently ranked among the top ten in their respective categories on the Japanese App Store, including the highly acclaimed PHYZIOS Sculptor. As a spin-off from Prometech Software, Phyzios specializes in gaming applications that utilize advanced physical simulation technology. This technology allows for the treatment of materials as particles with varying properties, providing developers with innovative tools for creating engaging applications across various touch panel devices.

PopIn Inc. is an online advertising services provider based in Tokyo, Japan, founded in July 2008 by Cheng Tao. The company focuses on developing information integration services that enhance the browsing experience for internet users. PopIn offers tools that measure the effectiveness of online advertisements by comparing the estimated reading time of ads with the actual time users spend on websites. As of May 2015, PopIn operates as a subsidiary of Baidu Japan, Inc. The company's mission is to assist users in efficiently addressing their online needs while creating innovative browsing solutions.

Tella, Inc. is a biotechnology company based in Tokyo, Japan, specializing in the research and development of regenerative and cell medicines, particularly dendritic cell vaccine therapy for cancer treatment. The company collaborates with affiliated medical institutions, offering techniques and operational expertise in dendritic cell vaccine therapy. Tella provides comprehensive consultation services that include the establishment and maintenance of cell processing centers, management systems for cell cultivation, and training for cell cultivation technicians. Additionally, the company supports contract medical institutions by offering training on treatment practices, documentation for therapy assessment, and information services for both physicians and patients. Founded in 2004, Tella aims to maximize immune responses in cancer therapies through its innovative approaches and support services.

NanoCarrier Co., Ltd. is a pharmaceutical company based in Kashiwa, Japan, specializing in the research, development, production, and sale of pharmaceutical products utilizing micellar nanoparticle technology. Founded in 1996, the company focuses primarily on cancer treatments, boasting a diverse product pipeline that includes NC-6004, a Cisplatin micelle targeting various cancers such as pancreatic and non-small cell lung cancer; VB-111, an Adeno 5 vector designed for rGBM and ovarian cancer; and NC-6300, which utilizes Epirubicin micelle for soft tissue sarcoma. Additional offerings include NC-4016, a Dach-platinum micelle for solid tumors, and NK105, a Paclitaxel micelle aimed at breast and gastric cancers. With a commitment to advancing cancer therapeutics, NanoCarrier continues to innovate in the pharmaceutical industry.

Tella, Inc. is a biotechnology company based in Tokyo, Japan, specializing in the research and development of regenerative and cell medicines, particularly dendritic cell vaccine therapy for cancer treatment. The company collaborates with affiliated medical institutions, offering techniques and operational expertise in dendritic cell vaccine therapy. Tella provides comprehensive consultation services that include the establishment and maintenance of cell processing centers, management systems for cell cultivation, and training for cell cultivation technicians. Additionally, the company supports contract medical institutions by offering training on treatment practices, documentation for therapy assessment, and information services for both physicians and patients. Founded in 2004, Tella aims to maximize immune responses in cancer therapies through its innovative approaches and support services.

Tella, Inc. is a biotechnology company based in Tokyo, Japan, specializing in the research and development of regenerative and cell medicines, particularly dendritic cell vaccine therapy for cancer treatment. The company collaborates with affiliated medical institutions, offering techniques and operational expertise in dendritic cell vaccine therapy. Tella provides comprehensive consultation services that include the establishment and maintenance of cell processing centers, management systems for cell cultivation, and training for cell cultivation technicians. Additionally, the company supports contract medical institutions by offering training on treatment practices, documentation for therapy assessment, and information services for both physicians and patients. Founded in 2004, Tella aims to maximize immune responses in cancer therapies through its innovative approaches and support services.